l ascorbic acid 2 phosphate (Merck & Co)
86
Structured Review
Merck & Co
l ascorbic acid 2 phosphate
L Ascorbic Acid 2 Phosphate, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ascorbate2-phosphate/2+ascorbate+phosphate/pmc12354898-263-15-17
Average 86 stars, based on 1 article reviews
L Ascorbic Acid 2 Phosphate, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ascorbate2-phosphate/2+ascorbate+phosphate/pmc12354898-263-15-17
Average 86 stars, based on 1 article reviews
l ascorbic acid 2 phosphate - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Control:Article Title: Bioengineered mPCL scaffolds with LiCl-stimulated hPDLCs cell sheets for enhanced periodontal regeneration. Article Snippet: 1 School of Dentistry, The University of Queensland, Herston, QLD 4006, Australia 2 School of Dentistry, Centre for Orofacial Regeneration, Rehabilitation and Reconstruction (COR3), The University of Queensland, Brisbane, QLD 4006, Australia 3 State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, China Abstract Objectives This study aimed to evaluate the efficacy of a Wnt pathway activator, lithium chloride (LiCl), and LiCl-stimulated human primary periodontal ligament cells (hPDLCs) cell sheets integrated with medical-grade melt-electrowritten polycaprolactone (mPCL) scaffolds for in vivo periodontal regeneration.. Methods This study followed a three-stage experimental design.. The first stage consisted of local administration of various concentrations of LiCl (10, 100, and 1000 mM) in rat periodontal defects for 3 weeks to evaluate its dosage effects on in vivo periodontal regeneration. Cell Culture:Article Title: Bioengineered mPCL scaffolds with LiCl-stimulated hPDLCs cell sheets for enhanced periodontal regeneration. Article Snippet: 1 School of Dentistry, The University of Queensland, Herston, QLD 4006, Australia 2 School of Dentistry, Centre for Orofacial Regeneration, Rehabilitation and Reconstruction (COR3), The University of Queensland, Brisbane, QLD 4006, Australia 3 State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, China Abstract Objectives This study aimed to evaluate the efficacy of a Wnt pathway activator, lithium chloride (LiCl), and LiCl-stimulated human primary periodontal ligament cells (hPDLCs) cell sheets integrated with medical-grade melt-electrowritten polycaprolactone (mPCL) scaffolds for in vivo periodontal regeneration.. Methods This study followed a three-stage experimental design.. The first stage consisted of local administration of various concentrations of LiCl (10, 100, and 1000 mM) in rat periodontal defects for 3 weeks to evaluate its dosage effects on in vivo periodontal regeneration. Recombinant:Article Title: Starch-Gelatin-Based Scaffolds for Cartilage Defect Repair: An in vitro Study Supporting Its Potential Clinical Use Article Snippet: The enzyme solution was removed after centrifugation at 200 × g and by 2 washing steps with DMEM/F-12, antibiotics and 10% fetal bovine serum (FBS; South America CE, Thermo Fisher Scientific). .. The pellet was resuspended in chondrogenic medium (DMEM/F-12 supplemented with antibiotics), 10% FBS (#10270106; FBS South America CE, Thermo Fisher Scientific), 40 μg/ml proline (#P0380; Merck), 50 μg/ml Article Title: Starch-Gelatin-Based Scaffolds for Cartilage Defect Repair: An in vitro Study Supporting Its Potential Clinical Use. Article Snippet: The enzyme solution was removed after centrifugation at 200 × g and by 2 washing steps with DMEM/F-12, antibiotics and 10% fetal bovine serum (FBS; South America CE, Thermo Fisher Scientific). .. The pellet was resuspended in chondrogenic medium (DMEM/F-12 supplemented with antibiotics), 10% FBS (#10270106; FBS South America CE, Thermo Fisher Scientific), 40 μg/ml proline (#P0380; Merck), 50 μg/ml Suspension:Article Title: Collagen VI microfibril structure reveals mechanism for molecular assembly and clustering of inherited pathogenic mutations Article Snippet: .. Proteins were transiently expressed in Expi293F suspension cells according to manufacturers’ instructions, with 50 μg/ml Transfection:Article Title: Collagen VI microfibril structure reveals mechanism for molecular assembly and clustering of inherited pathogenic mutations Article Snippet: .. Proteins were transiently expressed in Expi293F suspension cells according to manufacturers’ instructions, with 50 μg/ml other:Article Title: Attachment promoting compounds significantly enhance cell proliferation and purity of bovine satellite cells grown on microcarriers in the absence of serum. Article Snippet: It is composed of DMEM (A14430-01, GibcoTM, Thermo Fisher Scientific), 5.55 mM glucose (G7021, SigmaAldrich), 2 mM GlutaMAXTM (35050061, Thermo Fisher Scientific), 0.5 mM sodium pyruvate (P2256, Sigma-Aldrich), 10 ng/mL EGF1 (IK0100, ORF Genetics), 0.5 mg/mL human serum albumin (RHAC-NW, Richcore), 40 μM L-ascorbic |